Strategies for Effective Negotiations with PBMs: Understanding the Current State of the Law and Anticipated Legal and Policy Changes that May Impact Data Transfer and Transparency Requirements
Please join Morgan Lewis partner Andrew Ruskin for a one hour presentation to discuss advanced strategies for Counsel and their Government pricing clients on Medicaid and Medicare pricing and reimbursement including:
-
Positioning your company to best negotiate with PBMs
-
Comprehending the PBM mindset and criteria for deal-making
-
Transparency and PBMs: lessons for drug manufacturers
-
Forced PBM transparency under Part D
-
Effect of Corporate Drug- Purchasing Coalition transparency
-
What are the ramifications of making data available beyond the government?
-
Overcoming the explosion of FCA cases due to the analysis and use of data by the government
-
What are the ramifications of making data available beyond the government?
-
Devising strategies for PBMs to respond to the challenges of new and proposed rules and data sets being release within a five month period
-
Techniques for ensuring firewalls when working with PBMs that have Federal healthcare program business and commercial business
-
Understanding the relationship between the PBM and its customers, and the implications of the Anti-Kickback Statute and False Claims Act to those relationships
when
Monday, June 23, 2014
4:15 pm–5:15 pm
where
The Carlton Hotel
New York, NY